Transitioning Stable Patients with Pulmonary Arterial Hypertension from Parenteral Prostanoids to Oral Selexipag

INTRODUCTION: Parenteral prostanoids are the most potent therapies for pulmonary arterial hypertension (PAH) but are associated with complications and lifestyle limitations. Carefully selected stable patients may be considered for a transition from parenteral prostanoids to a more convenient oral re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinkamp, Colin, Bartolome, Sonja, Mims, Edward, Chin, Kelly, Shah, Trushil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710435/
https://www.ncbi.nlm.nih.gov/pubmed/36465803
http://dx.doi.org/10.1159/000526190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710435/
https://www.ncbi.nlm.nih.gov/pubmed/36465803
http://dx.doi.org/10.1159/000526190

Ejemplares similares